| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Inogen (NASDAQ:INGN) raises FY2025 sales outlook from $352.000 million-$355.000 million to $354.000 million-$357.000 million vs...
Inogen (NASDAQ:INGN) sees Q3 sales of $91.000 million-$93.000 million vs $93.267 million analyst estimate.
B. Riley Securities analyst Anderson Schock initiates coverage on Inogen (NASDAQ:INGN) with a Buy rating and announces Price...